As we settle into the year 2026, a new phase of health diplomacy is unfolding across Africa, with countries committing to faster disease data sharing, enhanced surveillance systems, and specific pandemic preparedness standards.

Development Diaries reports that the United States signed bilateral health cooperation agreements with 14 African countries in December 2025, creating a framework for collaboration on HIV, malaria, outbreak response, and health system strengthening.

Countries involved range from Kenya and Rwanda to Nigeria, Mozambique, and the Ivory Coast. On the surface, the message is that Africa is attracting renewed global investment in health at a time of growing pandemic risk and chronic system strain.

But beneath the announcements lies a more complex governance question that citizens should not ignore. These agreements are not neutral acts of generosity. They are negotiated instruments with conditions, expectations, and trade-offs.

In exchange for financial and technical support, participating countries are committing to faster disease data sharing, enhanced surveillance systems, and specific pandemic preparedness standards.

Some of the MoUs also sit alongside broader economic and trade negotiations, blurring the line between health cooperation and geopolitical leverage.

This matters because the system at stake is health sovereignty. For example, Kenya’s agreement with the United States is expected to unlock up to $1.6 billion in support over five years, while the Kenyan government commits to increasing its own health spending by $850 million.

That scale of investment could significantly strengthen disease control, primary care, and health infrastructure. Yet the deal has already raised domestic concerns, with Kenya’s High Court temporarily freezing its implementation pending a January 16 hearing, after civil society groups questioned data privacy protections and whether Parliament was bypassed in approving the agreement.

The pause underscores a crucial point of health partnerships that sidestep democratic oversight, risking undermining trust, even when funding is substantial.

Nigeria has also announced what it describes as a landmark health security agreement with the United States, aimed at strengthening primary healthcare and outbreak preparedness.

In a country where underfunded clinics and workforce shortages remain persistent, external support can be valuable. But value depends on alignment. If agreements prioritise donor reporting requirements over local health needs, or surveillance over service delivery, the impact on ordinary Nigerians will be limited.

Notably, some major African states, such as South Africa, Tanzania, and the Democratic Republic of Congo, were left out amid diplomatic frictions. U.S. officials cited concerns over governance issues, including restrictions on free expression and election-related violence, as reasons for reconsidering or delaying cooperation, particularly with Tanzania.

In South Africa’s case, foreign policy tensions have slowed negotiations. The implication is that access to health partnerships is increasingly entangled with political alignment and diplomatic favour.

This selective engagement raises equity concerns at continental level, as health threats do not respect borders. Excluding populous or high-burden countries from cooperation frameworks weakens regional preparedness and deepens uneven capacity across Africa.

Citizens in excluded countries still face disease outbreaks, workforce shortages, and fragile systems, regardless of diplomatic disputes.

Alongside these bilateral deals, African governments are also pursuing collective solutions. Health ministers, working with the World Health Organisation, are advancing the Africa Health Workforce Agenda 2035, a ten-year plan to address the chronic shortage of doctors, nurses, and midwives across the continent.

Taken together, these developments show a continent actively seeking to improve health delivery and preparedness through multiple channels. But activity is not the same as accountability.

The core risk is that health diplomacy becomes something done above citizens’ heads. Data-sharing commitments, surveillance infrastructure, and financing terms have real implications for privacy, national autonomy, and budget priorities.

When agreements are negotiated without parliamentary scrutiny or public explanation, citizens are asked to trust outcomes they were never allowed to question.

The responsibility here is shared. National governments must ensure that health agreements are transparent, debated, and aligned with domestic health priorities.

For their part, parliaments must assert their oversight role, especially where data governance and long-term financial commitments are involved. Regional bodies must push for inclusivity so that geopolitical disputes do not leave entire populations exposed.

Africans also have a role in asking who benefits from these partnerships, how funds will be used, what data is shared, and what safeguards exist. 

The continent needs global health partnerships. But it also needs health sovereignty, democratic oversight, and equity between countries and within them.

As new deals are signed and announced, the measure of success should not be the size of funding envelopes or the number of MoUs, but whether ordinary people are healthier, safer, and better protected.

Otherwise, Africa risks entering a new era of health diplomacy where agreements multiply, headlines improve, and systems remain just as vulnerable as before.